By James W. Arbogast, PhD
Hospitals measure hand hygiene compliance closely, but compliance alone doesn’t guarantee effective protection. Procurement leaders can help close the gap by evaluating what products actually deliver at the point of care.
Hospital-acquired infections are one of the clearest examples of how operational decisions become financial outcomes in healthcare.
When infection rates rise, the consequences are measurable across the organization: patient harm, longer lengths of stay, increased labor burden, reimbursement pressure, public reporting scrutiny and, for some hospitals, direct Medicare penalties tied to safety performance. Health systems invest enormous resources trying to reduce these risks because the cost of failure is well understood.
What is less understood is how often hospitals measure the activity of infection prevention more rigorously than the effectiveness of it.
Hand hygiene is a clear example. Hospitals track whether hand hygiene happens, but they often lack a standardized way to confirm whether each event achieves what it is intended to do: reduce microbial risk. For procurement teams, that distinction matters. The products they select do not simply support compliance; they help determine whether compliance translates into significant infection risk reduction and reduced payments due to hospital acquired conditions (HACs).
For years, hand hygiene procurement has largely centered on familiar questions: What is the cost per bottle? Is the dispenser compatible with our facilities? Can the product be delivered reliably? Will staff tolerate the formulation?
These are important considerations. But they do not answer the most important question: does the product, as dispensed and used in real-world conditions, deliver effective hand hygiene antimicrobial efficacy?
That question should matter deeply to procurement leaders.
Hand hygiene is one of the most visible and frequently measured patient safety practices in healthcare. Hospitals invest significant time and resources into monitoring whether healthcare workers clean their hands at the right moments. Compliance rates are tracked, reported and used as indicators of quality performance.
Yet compliance alone does not confirm that hand hygiene was effective. It only confirms that an event occurred. It does not necessarily confirm whether that event delivered the antimicrobial protection clinicians and patients assume — including whether enough product was dispensed, whether hands stayed wet long enough, or whether the efficacy demonstrated in testing is being supported at the point of use.
That distinction has major procurement implications.
Measuring effective hand hygiene
When a health system purchases an alcohol-based hand rub, it is not simply buying a consumable. It is buying a critical component of an infection prevention system. The product, dispenser, dose volume, dry time, formulation and user experience all interact. If any one of those elements is misaligned, a hospital may be measuring adherence more precisely than it is validating protection.
That is the measurement illusion: a hospital can count hand hygiene events without knowing whether each counted event is consistently capable of delivering the intended microbial reduction.
Procurement professionals are uniquely positioned to help close that gap.
The traditional purchasing lens often rewards low cost per milliliter or low cost per case. But in hand hygiene, the better measure may be cost per effective use. A product that appears economical on paper may deliver too little volume per actuation, dry too quickly, require multiple pumps to achieve adequate coverage, or fail to align with the wet-time expectations embedded in clinical guidance. In those cases, the lowest unit price does not translate to the best value and could actually cause avoidable cost to the healthcare system due to HAC penalties.
This is not a call for procurement teams to become microbiologists. It is a call for procurement to ask more rigorous questions of suppliers and to partner with infection prevention colleagues to ensure the supplier evidence is appropriate and sufficient.
What dose volume of hand sanitizer is delivered per actuation? How does that dose support coverage across a range of hand sizes plus skin conditions? What wet time does the product typically provide under real-use conditions? How does the system help healthcare workers meet recommended technique expectations? Does the product’s efficacy data use the proper in vivo test methods and reflect the amount actually dispensed in practice? Can the supplier connect product design to measurable performance, not just convenience, preference or price?
These questions are not academic. They determine whether a hand hygiene program is built on a strong operational foundation that delivers significant infection risk reduction, not built on a series of assumptions focused on cost per use only.
Make hand hygiene a system decision
In many hospitals, infection prevention, nursing, environmental services, facilities and procurement teams all touch hand hygiene decisions, but they may not be evaluating the same definition of value. Infection prevention may be focused on compliance and efficacy. Facilities may be focused on dispenser placement and maintenance. Nursing may be focused on skin feel and usability. Procurement may be focused on pricing, contracts and supply continuity.
All of those priorities are valid. The challenge is that they must be integrated.
A hand hygiene product that clinicians dislike will not support compliance. A product that cannot be supplied reliably creates operational risk. A dispenser that is difficult to maintain burdens facilities teams. But a product that is inexpensive, available and well-liked still falls short if it does not support effective use at the point of care.
That is why procurement decisions should be made through a system-value lens. The goal should not be to purchase the least expensive hand hygiene product. The goal should be to purchase a hand hygiene system that supports consistent, measurable and clinically meaningful use.
This shift is especially important as healthcare organizations face rising cost pressures. It can be tempting to view hand hygiene as a mature category where most products are essentially interchangeable. But interchangeability is a dangerous assumption. Small differences in formulation, dispensing volume and user experience can have meaningful consequences for how products perform in practice and compliance.
Procurement teams already understand this logic in other categories. They know that the cheapest device, instrument or technology is not always the lowest-risk or highest-value choice. They evaluate total cost of ownership, service burden, reliability, training needs and performance outcomes. Hand hygiene deserves the same discipline and rigor.
The opportunity is not simply to buy better products. It is to strengthen the bridge between purchasing decisions, infection prevention teams and patient safety outcomes.
Procurement professionals should have a seat at the table not only when contracts are negotiated, but when performance expectations and evidence requirements are defined. They should be empowered to challenge suppliers to provide scientifically sound test data, clarify assumptions and demonstrate how their systems support the clinical intent behind hand hygiene protocols.
Infection prevention cannot rest on compliance metrics alone. And procurement cannot rest on unit cost alone.
If healthcare leaders want hand hygiene programs that are both operationally efficient and clinically meaningful, they need purchasing standards that reflect how products actually work in the hands of healthcare workers. That means evaluating value by performance, not just price. It means treating dose, dispensing and wet time as procurement considerations, not technical afterthoughts. And it means recognizing that the right hand hygiene system can help turn a routine purchasing decision into a stronger patient safety strategy.
The goal is not to make hand hygiene procurement more complicated. It is to make sure the products deliver performance for hard working healthcare personnel at the point of care. If healthcare systems are going to count hand hygiene as protection, they should be confident each counted event is capable of protecting.
For procurement leaders, the mandate is clear: do not just ask what hand hygiene costs. Ask what it delivers.